MERCELINE OBUONG: Open Payments
NPI 1306247598 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$951 in 38 payments from 11 companies in 2025. Trend: 2023 $396 · 2024 $570 · 2025 $951
Food & beverage: $951
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 5 | $211 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $125 |
| Collegium Pharmaceutical, Inc. | 6 | $114 |
| Medtronic, Inc. | 5 | $105 |
| Nalu Medical, Inc. | 2 | $97 |
| TerSera Therapeutics LLC | 3 | $84 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $64 |
| ABBVIE INC. | 3 | $61 |
| PFIZER INC. | 3 | $56 |
| Valinor Pharma, LLC | 1 | $20 |
Products named: WaveWriter Alpha Prime 16, RELISTOR, XTAMPZA, INTELLIS ADAPTIVESTIM, Nalu Neurostimulation System, Prialt, JOURNAVX, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
